New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge.
about
New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@en
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@nl
type
label
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@en
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@nl
prefLabel
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@en
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@nl
P2093
P2860
P356
P1476
New Vaccine Formulations Conta ...... Leishmania infantum Challenge.
@en
P2093
Ana Paula Fernandes
Ana Paula M M Almeida
Caroline Junqueira
Daniel Doro
Frederico C Nascimento
Leonardo Damasceno
Leopoldo F M Machado
Ricardo Tostes Gazzinelli
P2860
P356
10.3389/FIMMU.2018.00465
P577
2018-03-15T00:00:00Z